Day Zero Diagnostics
  • About Us
    • Leadership
    • Board of Directors
    • Advisory Board
    • Careers
    • Contact us
  • Technology
    • Sample Preparation
    • Computational Diagnostic Algorithms
    • Big Data
  • Antibiotic Resistance
    • Problem
    • Current Treatment
    • DZD’s Solution
  • Lab Services
  • Newsroom
    • Press Releases
    • In the News
    • Publications
  • About Us
    • Leadership
    • Board of Directors
    • Advisory Board
    • Careers
    • Contact us
  • Technology
    • Sample Preparation
    • Computational Diagnostic Algorithms
    • Big Data
  • Antibiotic Resistance
    • Problem
    • Current Treatment
    • DZD’s Solution
  • Lab Services
  • Newsroom
    • Press Releases
    • In the News
    • Publications

Category: Press Releases


28th February 2020

EpiXact® Helps Stop a Carbapenem-Resistant Acinetobacter baumannii Outbreak in a Burn ICU

6th November 2019

EpiXact® Used to Identify Drug-Resistant E. coli Transmitted by Fecal Microbiota Transplant

10th July 2019

DZD Presents at Presidential Advisory Council on Combating Antibiotic Resistant Bacteria

10th July 2019

DZD Awarded SBIR Phase 1 Grant from NIH

3rd June 2019

DZD Launches Rapid Sequencing Service for Healthcare-Associated Infection Investigations

15th March 2019

Day Zero Diagnostics Presents at the Future of Individualized Medicine Conference

23rd January 2019

DZD Announces Completion of $8.6M Series A

5th October 2018

Day Zero Diagnostics Selected as a 2018 TedMed Hive Innovator

26th September 2017

Day Zero Diagnostics is 2017 MedTech Innovator Global Competition Winner

7th August 2017

DZD Announces Completion of $3M Series Seed Raise

23rd March 2016

Day Zero Diagnostics Named 2016 HBSAB New Venture Competition Winner

  • Newer
  • 1
  • 2

Recent Posts

  • IDWeek Spotlights New Rapid ID Diagnostics in the Pipeline
  • Day Zero Diagnostics Presents at 2024 ASM Microbe Conference
  • AI Enables Faster, More Effective Antibiotic Treatment of Sepsis
  • Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
  • Day Zero Diagnostics inks new partnership for bloodstream infection diagnostics

Recent Comments

    250 Arsenal Place, Suite 320
    Watertown, MA 02472

    info@dayzerodiagnostics.com

    © 2025

    Day Zero Diagnostics Inc. Terms.

    Top